Recce Pharmaceuticals (ASX: RCE) Share Price

RCE

$0.48–+0.00%

$138.8MRank #753 on ASXHealthcareBiotechnology

Prices updated 20 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$138.8M

Volume

66K

P/E Ratio

-2.84

EPS

-$0.0573

Dividend Yield

0.00%

52-Week High

$0.73

52-Week Low

$0.285

Beta

0.389

Recce Pharmaceuticals (ASX: RCE) is an Australian-listed company in the Healthcare sector with a market capitalisation of $138.8M and the 753rd-largest security on the ASX by market capitalisation. The RCE share price is $0.48, up 0.00% today and up 62.71% over the past 12 months. Shares have traded between $0.285 and $0.73 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Recce Pharmaceuticals reported revenue of $0 and a net loss of $16.6M.

Charts

$0.48

24H Range

$0.48

$0.485

52-Week Range

$0.285

$0.73

About Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltd operates as a biotechnology enterprise, concentrating on the research, advancement, and market introduction of synthetic anti-infective treatments across Australia, the United States, and the United Kingdom. The company's foremost developmental drug, RECCE 327, is intended to address blood infections and sepsis caused by E. coli and S. aureus bacteria, including their antibiotic-resistant variants. Additionally, Recce is progressing RECCE 529, a synthetic anti-infective targeting viral illnesses, and RECCE 435, another synthetic polymer anti-infective. Founded in 2007, the firm, which was initially named Recce Limited, officially became Recce Pharmaceuticals Ltd in November 2017. Its corporate headquarters are situated in Sydney, Australia.

IPO Date

14 Jan 2016

CEO

James Hamilton-Bray Graham

Website

recce.com.au

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-16.6M
Total Assets	$2.0M
Total Debt	$11.3M
Free Cash Flow	$-10.3M
Return on Equity	88.95%
Profit Margin	—
Operating Margin	—

RCE Frequently Asked Questions

What is the Recce Pharmaceuticals (ASX: RCE) share price?

The RCE share price is $0.48, up 0.00% for the day, based on the latest available ASX market data.

What is Recce Pharmaceuticals's market capitalisation?

Recce Pharmaceuticals has a market capitalisation of $138.8M, making it the 753rd-largest security listed on the ASX.

Does Recce Pharmaceuticals pay a dividend?

RCE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Recce Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), RCE reported revenue of $0 and a net loss of $16.6M.

How many RCE shares are on issue?

Recce Pharmaceuticals has approximately 289,183,423 shares on issue, based on its market capitalisation of $138.8M and current share price.

What sector is Recce Pharmaceuticals in?

Recce Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Recce Pharmaceuticals list on the ASX?

Recce Pharmaceuticals listed on the Australian Securities Exchange on 14 Jan 2016.

Latest News

A AU$23m Market Cap Boost Pleasing ToRecce Pharmaceuticals Insiders

simplywall.st28 May 2026

A AU$23m Market Cap Boost Pleasing ToRecce Pharmaceuticals Insiders simplywall.st

56% in a Year and Still Climbing — What’s Driving Recce Pharmaceuticals' (ASX:RCE) Momentum?

Kalkine27 May 2026

56% in a Year and Still Climbing — What’s Driving Recce Pharmaceuticals' (ASX:RCE) Momentum? Kalkine

Recce secures path to MENA commercialisation - ICYMI | ASX:RCE, OTC:RECEF

Proactive financial news28 May 2026

Recce secures path to MENA commercialisation - ICYMI | ASX:RCE, OTC:RECEF Proactive financial news

Insights: Recce Pharmaceuticals Ltd (ASX:RCE)

smallcaps.com.au30 Oct 2025

Insights: Recce Pharmaceuticals Ltd (ASX:RCE) smallcaps.com.au

While insiders own 25% of Recce Pharmaceuticals Ltd (ASX:RCE), retail investors are its largest shareholders with 55% ownership

Yahoo Finance26 Dec 2025

While insiders own 25% of Recce Pharmaceuticals Ltd (ASX:RCE), retail investors are its largest shareholders with 55% ownership Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
SDISDI Limited	$165.5M	$1.3925	8.38	2.08%	▲+0.18%
ATHAlterity Therapeutics Limited	$130.5M	$0.60	-2.12	0.00%	▲+2.56%
ACWActinogen Medical Limited	$125.6M	$0.035	-4.28	0.00%	▼-2.78%
ILAIsland Pharmaceuticals Limited	$88.8M	$0.355	-5.66	0.00%	▼-2.74%
ALAArovella Therapeutics Limited	$85.8M	$0.071	-14.80	0.00%	▼-1.39%
PARParadigm Biopharmaceuticals Limited	$73.7M	$0.17	-1.51	0.00%	▼-5.56%
BIOBiome Australia Limited	$60.4M	$0.265	19.71	0.00%	▼-3.64%
IMUImugene Limited	$47.8M	$0.115	-0.70	0.00%	▲+21.05%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$55.71B	$116.32	▼-52.76%
RMDResMed Inc.	$38.70B	$26.68	▼-30.94%
SIGSigma Healthcare Limited	$31.86B	$2.76	▼-13.55%
FPHFisher & Paykel Healthcare Corporation Limited	$18.52B	$31.53	▼-6.24%
PMEPro Medicus Limited	$18.05B	$172.80	▼-38.98%
MPLMedibank Private Limited	$13.36B	$4.85	▲+0.72%
SHLSonic Healthcare Limited	$9.91B	$20.05	▼-23.60%
RHCRamsay Health Care Limited	$9.08B	$39.49	▲+8.93%
COHCochlear Limited	$7.73B	$118.14	▼-60.13%
TLXTelix Pharmaceuticals Limited	$4.91B	$14.50	▼-42.16%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
19 June 2026	$0.485	$0.485	$0.48	$0.48	66K	–+0.00%
18 June 2026	$0.51	$0.51	$0.48	$0.48	150K	▼-2.04%
17 June 2026	$0.50	$0.50	$0.49	$0.49	60K	▼-1.01%
16 June 2026	$0.51	$0.51	$0.495	$0.495	82K	▼-1.98%
15 June 2026	$0.50	$0.505	$0.495	$0.505	4.8K	▲+2.02%
12 June 2026	$0.50	$0.50	$0.49	$0.495	69K	▲+1.02%
11 June 2026	$0.50	$0.505	$0.49	$0.49	188K	▼-4.85%
10 June 2026	$0.51	$0.515	$0.51	$0.515	30K	▲+1.98%
9 June 2026	$0.51	$0.51	$0.505	$0.505	202K	▼-1.94%
8 June 2026	$0.525	$0.525	$0.51	$0.515	64K	–+0.00%
5 June 2026	$0.525	$0.525	$0.51	$0.515	57K	▼-1.90%
4 June 2026	$0.52	$0.525	$0.515	$0.525	15K	▲+0.96%
3 June 2026	$0.535	$0.545	$0.515	$0.52	80K	▼-4.59%
2 June 2026	$0.54	$0.555	$0.52	$0.545	169K	▲+0.93%
1 June 2026	$0.555	$0.555	$0.535	$0.54	52K	▼-1.82%
29 May 2026	$0.565	$0.565	$0.545	$0.55	52K	▼-1.79%
28 May 2026	$0.58	$0.58	$0.55	$0.56	125K	▼-1.75%
27 May 2026	$0.53	$0.587	$0.53	$0.57	804K	▲+9.62%
26 May 2026	$0.49	$0.525	$0.48	$0.52	118K	▲+8.33%
25 May 2026	$0.475	$0.495	$0.475	$0.48	19K	▼-0.41%
22 May 2026	$0.50	$0.505	$0.48	$0.482	66K	▼-4.55%
21 May 2026	$0.487	$0.505	$0.485	$0.505	13K	▲+3.06%
20 May 2026	$0.49	$0.51	$0.47	$0.49	71K	▲+4.26%
19 May 2026	$0.475	$0.48	$0.47	$0.47	2.3K	–+0.00%
18 May 2026	$0.49	$0.49	$0.47	$0.47	24K	▼-1.05%
15 May 2026	$0.475	$0.477	$0.475	$0.475	2.4K	▲+3.26%
14 May 2026	$0.49	$0.49	$0.46	$0.46	210K	▼-6.12%
13 May 2026	$0.48	$0.495	$0.48	$0.49	16K	▲+3.16%
12 May 2026	$0.49	$0.49	$0.475	$0.475	16K	–+0.00%
11 May 2026	$0.505	$0.505	$0.475	$0.475	44K	▼-5.00%

Recce Pharmaceuticals (ASX: RCE) Share Price

RCE

$0.48–+0.00%

$138.8MRank #753 on ASXHealthcareBiotechnology

Prices updated 20 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$138.8M

Volume

66K

P/E Ratio

-2.84

EPS

-$0.0573

Dividend Yield

0.00%

52-Week High

$0.73

52-Week Low

$0.285

Beta

0.389

Charts

$0.48

24H Range

$0.48

$0.485

52-Week Range

$0.285

$0.73

About Recce Pharmaceuticals Ltd

IPO Date

14 Jan 2016

CEO

James Hamilton-Bray Graham

Website

recce.com.au

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-16.6M
Total Assets	$2.0M
Total Debt	$11.3M
Free Cash Flow	$-10.3M
Return on Equity	88.95%
Profit Margin	—
Operating Margin	—

RCE Frequently Asked Questions

What is the Recce Pharmaceuticals (ASX: RCE) share price?

The RCE share price is $0.48, up 0.00% for the day, based on the latest available ASX market data.

What is Recce Pharmaceuticals's market capitalisation?

Recce Pharmaceuticals has a market capitalisation of $138.8M, making it the 753rd-largest security listed on the ASX.

Does Recce Pharmaceuticals pay a dividend?

RCE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Recce Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), RCE reported revenue of $0 and a net loss of $16.6M.

How many RCE shares are on issue?

Recce Pharmaceuticals has approximately 289,183,423 shares on issue, based on its market capitalisation of $138.8M and current share price.

What sector is Recce Pharmaceuticals in?

Recce Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Recce Pharmaceuticals list on the ASX?

Recce Pharmaceuticals listed on the Australian Securities Exchange on 14 Jan 2016.

While insiders own 25% of Recce Pharmaceuticals Ltd (ASX:RCE), retail investors are its largest shareholders with 55% ownership

Yahoo Finance26 Dec 2025

While insiders own 25% of Recce Pharmaceuticals Ltd (ASX:RCE), retail investors are its largest shareholders with 55% ownership Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
SDISDI Limited	$165.5M	$1.3925	8.38	2.08%	▲+0.18%
ATHAlterity Therapeutics Limited	$130.5M	$0.60	-2.12	0.00%	▲+2.56%
ACWActinogen Medical Limited	$125.6M	$0.035	-4.28	0.00%	▼-2.78%
ILAIsland Pharmaceuticals Limited	$88.8M	$0.355	-5.66	0.00%	▼-2.74%
ALAArovella Therapeutics Limited	$85.8M	$0.071	-14.80	0.00%	▼-1.39%
PARParadigm Biopharmaceuticals Limited	$73.7M	$0.17	-1.51	0.00%	▼-5.56%
BIOBiome Australia Limited	$60.4M	$0.265	19.71	0.00%	▼-3.64%
IMUImugene Limited	$47.8M	$0.115	-0.70	0.00%	▲+21.05%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$55.71B	$116.32	▼-52.76%
RMDResMed Inc.	$38.70B	$26.68	▼-30.94%
SIGSigma Healthcare Limited	$31.86B	$2.76	▼-13.55%
FPHFisher & Paykel Healthcare Corporation Limited	$18.52B	$31.53	▼-6.24%
PMEPro Medicus Limited	$18.05B	$172.80	▼-38.98%
MPLMedibank Private Limited	$13.36B	$4.85	▲+0.72%
SHLSonic Healthcare Limited	$9.91B	$20.05	▼-23.60%
RHCRamsay Health Care Limited	$9.08B	$39.49	▲+8.93%
COHCochlear Limited	$7.73B	$118.14	▼-60.13%
TLXTelix Pharmaceuticals Limited	$4.91B	$14.50	▼-42.16%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
19 June 2026	$0.485	$0.485	$0.48	$0.48	66K	–+0.00%
18 June 2026	$0.51	$0.51	$0.48	$0.48	150K	▼-2.04%
17 June 2026	$0.50	$0.50	$0.49	$0.49	60K	▼-1.01%
16 June 2026	$0.51	$0.51	$0.495	$0.495	82K	▼-1.98%
15 June 2026	$0.50	$0.505	$0.495	$0.505	4.8K	▲+2.02%
12 June 2026	$0.50	$0.50	$0.49	$0.495	69K	▲+1.02%
11 June 2026	$0.50	$0.505	$0.49	$0.49	188K	▼-4.85%
10 June 2026	$0.51	$0.515	$0.51	$0.515	30K	▲+1.98%
9 June 2026	$0.51	$0.51	$0.505	$0.505	202K	▼-1.94%
8 June 2026	$0.525	$0.525	$0.51	$0.515	64K	–+0.00%
5 June 2026	$0.525	$0.525	$0.51	$0.515	57K	▼-1.90%
4 June 2026	$0.52	$0.525	$0.515	$0.525	15K	▲+0.96%
3 June 2026	$0.535	$0.545	$0.515	$0.52	80K	▼-4.59%
2 June 2026	$0.54	$0.555	$0.52	$0.545	169K	▲+0.93%
1 June 2026	$0.555	$0.555	$0.535	$0.54	52K	▼-1.82%
29 May 2026	$0.565	$0.565	$0.545	$0.55	52K	▼-1.79%
28 May 2026	$0.58	$0.58	$0.55	$0.56	125K	▼-1.75%
27 May 2026	$0.53	$0.587	$0.53	$0.57	804K	▲+9.62%
26 May 2026	$0.49	$0.525	$0.48	$0.52	118K	▲+8.33%
25 May 2026	$0.475	$0.495	$0.475	$0.48	19K	▼-0.41%
22 May 2026	$0.50	$0.505	$0.48	$0.482	66K	▼-4.55%
21 May 2026	$0.487	$0.505	$0.485	$0.505	13K	▲+3.06%
20 May 2026	$0.49	$0.51	$0.47	$0.49	71K	▲+4.26%
19 May 2026	$0.475	$0.48	$0.47	$0.47	2.3K	–+0.00%
18 May 2026	$0.49	$0.49	$0.47	$0.47	24K	▼-1.05%
15 May 2026	$0.475	$0.477	$0.475	$0.475	2.4K	▲+3.26%
14 May 2026	$0.49	$0.49	$0.46	$0.46	210K	▼-6.12%
13 May 2026	$0.48	$0.495	$0.48	$0.49	16K	▲+3.16%
12 May 2026	$0.49	$0.49	$0.475	$0.475	16K	–+0.00%
11 May 2026	$0.505	$0.505	$0.475	$0.475	44K	▼-5.00%